Group One Trading
DWTX

Group One Trading’s Dogwood Therapeutics DWTX Stock Holding History

Group One Trading’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14 Hold
9
– – ﹤0.01% 7446
2026
Q1 		$19 Hold
9
– – ﹤0.01% 7464
2025
Q4 		$37 Hold
9
– – ﹤0.01% 7945
2025
Q3 		$69 Hold
9
– – ﹤0.01% 8256
2025
Q2 		$43 Hold
9
– – ﹤0.01% 7810
2025
Q1 		$45 Sell
9
-36
-80% -$244 ﹤0.01% 7427
2024
Q4 		$112 Sell
45
-7
-13% -$23 ﹤0.01% 7093
2024
Q3 		$220 Hold
52
– – ﹤0.01% 6450
2024
Q2 		$279 Sell
52
-272
-84% -$2.35K ﹤0.01% 6504
2024
Q1 		$3.89K Sell
324
-235
-42% -$2.64K ﹤0.01% 6282
2023
Q4 		$8.04K Buy
559
+100
+22% +$1.68K ﹤0.01% 6306
2023
Q3 		$10.6K Sell
459
-206
-31% -$7.16K ﹤0.01% 6306
2023
Q2 		$22.9K Buy
665
+90
+16% +$2.57K ﹤0.01% 5898
2023
Q1 		$5.28K Sell
575
-226
-28% -$1.8K ﹤0.01% 6255
2022
Q4 		$4.72K Buy
801
+340
+74% +$2.56K ﹤0.01% 6364
2022
Q3 		$4K Buy
+461
New +$65K ﹤0.01% 6969

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's DWTX Position: Q2 2026 in Review

Group One Trading held its Dogwood Therapeutics (DWTX) position steady in Q2 2026 at 9 shares worth $14. The position accounts for ﹤0.01% of the portfolio, ranked #7446.

Group One Trading first reported a position in DWTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $22.9K in Q2 2023. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Group One Trading held 9 shares of Dogwood Therapeutics worth $14 as of Q2 2026.
  • Group One Trading left its Dogwood Therapeutics share count unchanged in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7446 holding.
  • Group One Trading first reported a position in Dogwood Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Group One Trading's Dogwood Therapeutics position peaked at $22.9K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.